Postoperative respiratory morbidity in chronic obstructive pulmonary disease patients receiving botulinum toxin injection before abdominal wall surgery: A multicentric study.

Date publication

septembre 2025

Journal

Surgery

Auteurs

Membres identifiés du Cancéropôle Est :
Pr ORTEGA DEBALLON Pablo , Dr ROMAIN Benoit

Tous les auteurs :
Joliat GR, Ortega-Deballon P, Alsuwaidan H, Moszkowicz D, Romain B, Renard Y, Passot G

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/41033266

Résumé

Botulinum toxin A injection is often used before abdominal wall surgery. Because botulinum toxin A inhibits the lateral abdominal muscles that have a secondary role in the breathing biomechanics, potential concerns regarding postoperative respiratory morbidity in patients with chronic obstructive pulmonary disease have been raised. This study assessed the incidence of postoperative pneumonias after abdominal wall surgery in patients with chronic obstructive pulmonary disease with and without botulinum toxin A injection.

Référence

Surgery. 2025 09 30;188:109765